ArticleNational science review2022
Identification of TAZ as the essential molecular switch in orchestrating SCLC phenotypic transition and metastasis.
Erratum issuedOpen access · goldAbstract read
In one paragraph
Article in National science review, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.
0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 20 citations in OpenAlex.
- Integrating molecular subtypes, genomics and functional dependencies to identify context-specific therapeutic vulnerabilities in small cell lung cancer.Biomarker research · 2026Review
- SMARCA4 Loss Promotes Late-Stage Tumor Progression in Nonneuroendocrine Small Cell Lung Cancer.Molecular cancer research : MCR · 2026Article
- Small Cell Lung Cancer Classification: Unraveling Heterogeneity to Enable Personalized Treatments.Cancer research · 2026Review
- Chidamide suppresses macrophage-mediated immune evasion and tumor progression in small cell lung cancer by targeting the STAT4/CCL2 signaling pathway.Cancer biology & medicine · 2025Article
- SMARCA4 is essential for early-stage tumor development but its loss promotes late-stage cancer progression in small-cell lung cancer.bioRxiv : the preprint server for biology · 2025Article
- Intratumoral heterogeneity and potential treatment strategies in small cell lung cancer.Frontiers in oncology · 2025Review
- Integrative study of lung cancer adeno-to-squamous transition in EGFR TKI resistance identifies RAPGEF3 as a therapeutic target.National science review · 2024Article
- Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer.Nature reviews. Clinical oncology · 2024Review
- TET2-STAT3-CXCL5 nexus promotes neutrophil lipid transfer to fuel lung adeno-to-squamous transition.The Journal of experimental medicine · 2024Article
- Advances of E3 ligases in lung cancer.Biochemistry and biophysics reports · 2024Review
- PHD finger protein 10 promotes cell proliferation by regulating CD44 transcription in gastric cancer.Heliyon · 2024Article
- Dynamic phenotypic reprogramming and chemoresistance induced by lung fibroblasts in small cell lung cancer.Scientific reports · 2024Article
- Review
- Autophagic flux modulates tumor heterogeneity and lineage plasticity in SCLC.Frontiers in oncology · 2024Article
- Understanding SCLC heterogeneity and plasticity in cancer metastasis and chemotherapy resistance.Acta biochimica et biophysica Sinica · 2023Review
- Killing SCLC: insights into how to target a shapeshifting tumor.Genes & development · 2022Review
- Immunotherapy in Extensive-Stage Small Cell Lung Cancer.Current oncology (Toronto, Ont.) · 2021Review
Corrections and comments
- Erratum issued
Authors and funding
26 authors at 8 institutions in 3 countries.
Yujuan JinState Key Laboratory of Cell Biology, Chinese Academy of Sciences, Shanghai 200031, China.
Qiqi ZhaoState Key Laboratory of Cell Biology, Chinese Academy of Sciences, Shanghai 200031, China.
Weikang ZhuCenter for Excellence in Mathematical Sciences, National Center for Mathematics and Interdisciplinary Sciences, Key Laboratory of Management, Decision and Information System, Hua Loo-Keng Center for Mathematical Sciences, Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing 100190, China.
Yan FengState Key Laboratory of Cell Biology, Chinese Academy of Sciences, Shanghai 200031, China.
Tian XiaoShenzhen Key Laboratory of Translational Medicine of Tumor, Department of Cell Biology and Genetics, Shenzhen University Health Sciences Center, Shenzhen 518060, China.
Peng ZhangShanghai Pulmonary Hospital, Tongji University, Shanghai 200092, China.
Liyan JiangShanghai Chest Hospital, Shanghai Jiaotong University, Shanghai 200030, China.
Yingyong HouZhongshan Hospital, Fudan University, Shanghai 200032, China.
Chenchen GuoState Key Laboratory of Cell Biology, Chinese Academy of Sciences, Shanghai 200031, China.
Hsinyi HuangState Key Laboratory of Cell Biology, Chinese Academy of Sciences, Shanghai 200031, China.
Yabin ChenState Key Laboratory of Cell Biology, Chinese Academy of Sciences, Shanghai 200031, China.
Xinyuan TongState Key Laboratory of Cell Biology, Chinese Academy of Sciences, Shanghai 200031, China.
Jiayu CaoState Key Laboratory of Cell Biology, Chinese Academy of Sciences, Shanghai 200031, China.
Fei LiDepartment of Pathology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.
Xueliang ZhuState Key Laboratory of Cell Biology, Chinese Academy of Sciences, Shanghai 200031, China.
Jun QinCAS Key Laboratory of Tissue Microenvironment and Tumor, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Nutrition and Health Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
Dong GaoState Key Laboratory of Cell Biology, Chinese Academy of Sciences, Shanghai 200031, China.
Xin-Yuan LiuState Key Laboratory of Cell Biology, Chinese Academy of Sciences, Shanghai 200031, China.
Hua ZhangLaura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY 10016, USA.ORCID https://orcid.org/0000-0001-7704-4712
Luonan ChenState Key Laboratory of Cell Biology, Chinese Academy of Sciences, Shanghai 200031, China.ORCID https://orcid.org/0000-0002-3960-0068
Roman K ThomasDepartment of Translational Genomics, Center of Integrated Oncology Cologne-Bonn, Medical Faculty, University of Cologne, Cologne 50931, Germany.
Kwok-Kin WongLaura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY 10016, USA.
Lei ZhangState Key Laboratory of Cell Biology, Chinese Academy of Sciences, Shanghai 200031, China.
Yong WangCenter for Excellence in Mathematical Sciences, National Center for Mathematics and Interdisciplinary Sciences, Key Laboratory of Management, Decision and Information System, Hua Loo-Keng Center for Mathematical Sciences, Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing 100190, China.
Liang HuState Key Laboratory of Cell Biology, Chinese Academy of Sciences, Shanghai 200031, China.ORCID https://orcid.org/0000-0002-0984-9807
Hongbin JiState Key Laboratory of Cell Biology, Chinese Academy of Sciences, Shanghai 200031, China.ORCID https://orcid.org/0000-0003-0891-6390
Chinese Academy of Sciences · CNNYU Langone Health · USShanghai Chest Hospital · CNShanghai Medical College of Fudan University · CNShenzhen University Health Science Center · CNSun Yat-sen University · CNTongji University · CNUniversity of Cologne · DE
Funding
No grant is acknowledged in the PubMed record.
Abstract
Small-cell lung cancer (SCLC) is a recalcitrant cancer characterized by high metastasis. However, the exact cell type contributing to metastasis remains elusive. Using a
Indexed as
metastasisphenotypic transitionsmall cell lung cancerSWI/SNF complexTAZ
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.